Erythromycin base tablets

Details Erythromycin base tablets Erythromycin base tablets

1981-01-15

1982-07-20

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

Polymer from ethylenic monomers only

424181, A61K 936, A61K 3171

Patent

active

043405827

ABSTRACT:
An enteric coated erythromycin tablet is provided that produces essentially the same blood levels in fasting and nonfasting subjects. The tablet contains erythromycin base dihydrate and a highly water-soluble nontoxic salt in the core and the coating polymer is a hydroxypropyl methylcellulose phthalate.

REFERENCES:
patent: 2798024 (1957-07-01), Zapapas et al.
patent: 2864817 (1958-12-01), Croley
patent: 3242049 (1966-03-01), O'Brien et al.
patent: 3639565 (1972-02-01), Prillig
patent: 3784683 (1974-01-01), Prillig et al.
patent: 3789117 (1974-01-01), Tsujino
patent: 3865935 (1975-02-01), Amann
patent: 3960757 (1976-06-01), Morishita et al.
patent: 3962419 (1976-06-01), Mayama et al.
patent: 3981984 (1976-09-01), Signorino
patent: 4001390 (1977-01-01), Ohno et al.
patent: 4013820 (1977-03-01), Farhadish et al.
patent: 4017647 (1977-04-01), Ohno et al.
patent: 4101651 (1978-07-01), Kobayashi et al.
patent: 4127647 (1978-11-01), Sato et al.
patent: 4226981 (1980-10-01), Onda et al.
patent: 4287221 (1981-09-01), Tonedachi et al.
patent: 4289751 (1981-09-01), Windheuser
Watanabe et al., Nippon Yakugakkai Yakugaku Zasshi, 97(7):791-800, (1977).
Pelizza et al., Il Farmaeo 31(4): 254-263, (1976).
Eckert Pharmazeutische Industrie, 38(9): 836-841, (1976).
Mannisto et al., Arzneimittel-Forschung, 25(11): 1828-1831, (1975).
Robertson et al., J. Pharm. Sci., 61(10):1633-1635, Oct. 1972.
Koroleva et al., Antibiotiki, 14(12):1084-1088, (1969).
Goodwin, Medical Journal of Australia, 1:1280, (1967).
Shtol'ts et al., Antibiotiki, 11(4):291-4, (1966).
Gruber et al., J. Am. Pharm. Assn., 47:867-869, (1958).
Rose Anal. Chem., 26:938-939, (1954).
Bauer et al., Pharmazeutische Industrie, 41(12):1203-1207, (1979).
Dette Infection, (Munich), 7(3):129-145, (1979).
Watanabe et al., Nippon Yakugakkai Yakugaku Zasshi, 98(8):1092-1100, (1978).
Allen et al., J. Pharm. Sci., 67(8):1087-1093, Aug. 1978.
Springolo Bollettino Chimico-Farmaceutico, 117(2):113-121, (1978).
Spitall Pharmazeutische Industrie, 39(5):502-505, (1977).
Chun et al., Infection, 5(Suppl. 1):14-22, (1977).
McDonald et al., J. Clinical Pharmacology, 17(10 pt. 1):601-606, (1977).
Osterwald et al., ACTA Pharmaceutica Technologica, 27(1):47-60, (1981).
Osterwald et al., ACTA Pharmaceutica Technologica, 26(3):201-209, (1980).
DiSanto et al., J. Clin. Pharmacol., 20(7):437-443; (1980).
Piros Gyogyszereszet, 24(12):460-466, (1980).
Yakatan et al., J. Pharmacokinetics Biopharmaceutics, 7(4):355-368, (1979).
Watanabe et al., Nippon Yakugakkai Yakagaku Zasshi, 99(3):308-314, (1979).
Tomasini et al., Farmatsiya, (Sofia), 29(2):16-22, (1979).
Bechtol et al., Current Therapeutic Research, 25(5):618-625, (1979).

Affiliated with

Also associated with

Rating

Erythromycin base tablets does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythromycin base tablets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythromycin base tablets will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-250068